New app could make insulin dosing safer for type 1 diabetes patients
NCT ID NCT06974201
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a smartphone app called Diabetes:M that helps people with type 1 diabetes figure out the right insulin dose based on their food intake and blood sugar levels. Thirty adults will use the app for two weeks and compare their blood sugar control to a two-week period without the app. The goal is to see if the app improves time spent in a healthy blood sugar range and reduces dangerous lows or highs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Diabetes:M bolus calculator app
What this could lead to
If successful, this app could help people with type 1 diabetes manage their insulin dosing more accurately, reducing dangerous blood sugar swings.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply to everyone. The app may not work better than standard methods for all users.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital for Active Treatmnet in Endocrinology "Acad Ivan Penchev" EAD, Medical University of Sofia
Sofia, 1431, Bulgaria